Daniel Gross
Co-Founder @ Pioneer
San Francisco, United States
Daniel Gross is a seed investor at Pioneer in San Francisco focused on Software and Artificial Intelligence. Daniel Gross is the Co-Founder of Pioneer. He previously worked at Y Combinator as a Head of AI.
- Total investments:
- 101
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Daniel Gross invests in
Stages Daniel Gross invests in
Countries Daniel Gross invests in
Round sizes
Round size
- Seed
- $2M–$20M
- Series A
- $12M–$34M
- Series B
- $25M–$130M
Investment Focus
Industry
- Software 28 (28%)
- Artificial Intelligence 24 (24%)
- Information Technology 13 (13%)
- Machine Learning 12 (12%)
- Health Care 5 (5%)
Stage
- Seed 28 (28%)
- Series A 22 (22%)
- Series B 14 (14%)
- Funding Round 10 (10%)
- Pre-Seed 8 (8%)
Country
- United States 60 (59%)
- India 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs. | $435M / Series C / Jun 02, 2026 | |
|
|
AI note-taking solution | $125M / Series C / Mar 25, 2026 | |
|
|
Reinventing knowledge work in your browser | $5.6M / Seed / Sep 30, 2025 | |
|
|
Making cloud savings automated, effortless, and risk-free Start saving in 2 minutes; no code or engineering is required. | $20M / Series A / Jun 12, 2025 | |
|
|
Creatify AI provides a platform for creating user-generated content UGC style video ads. Users can generate multiple video ads by simply pasting a product link, utilizing a library of AI avatars for a more engaging presentation. The service automates video production, allowing users to produce ads quickly and efficiently. Additionally, Creatifyoffers tools for performance marketers to analyze their advertising strategies and gain insights into their competition. This combination of video creation and analytical features supports sales teams in enhancing their marketing efforts and improving engagement with potential customers. | $15.5M / Series A / May 28, 2025 | |
|
|
AI note-taking solution | $43M / Series B / May 14, 2025 | |
|
|
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs. | $130M / Series B / May 06, 2025 | |
|
|
Freed is an AI scribe that listens, transcribes, and writes SOAP notes in real time—saving clinicians hours on documentation. It generates comprehensive SOAP notes quickly, enhancing work efficiency. Freed's platform listens, transcribes, and generates comprehensive clinical notes during patient visits. Clinicians initiate the process bystarting the app at the beginning of a visit; the AI captures the conversation and produces structured notes within 60 seconds after concluding the visit. These notes can be reviewed and seamlessly integrated into electronic health records (EHRs). | $30M / Series A / Mar 05, 2025 | |
|
|
Portola develops the Tolan app, an AI companion that features animated alien personalities for conversational support. The platform matches users with a personalized virtual friend through a personality interview, then evolves that relationship via memory and daily reflection, helping users feel more grounded amid modern pressures. Tolan engages invoice-based chat and can analyze images, enabling natural, context-aware interactions. | $10M / Seed / Feb 26, 2025 | |
|
|
Pulse converts complex information into LLM-ready inputs. Their API supports all document formats, from PDFs to Word, Excel, etc. Pulse integrates seamlessly with any existing data pipeline in minutes without any training or complexity. It was founded in 2024 and is located in San Francisco, California, United States. | $3.9M / Seed / Feb 19, 2025 | |
| See all 101 investments → | |||
Co-Investors
About Pioneer
A home for founders on day 0
Pioneer Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Daniel Gross
Co-Founder
|
|||
|
Ibukunoluwa Salau
Pioneer
|
|||
|
Rishi Narang
Co-founder and CEO
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Daniel Gross invest in?
Daniel Gross invests primarily in Software, Artificial Intelligence and Information Technology startups, most often at Seed and Series A stage. Most of the 101 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Daniel Gross's check size?
Daniel Gross typically joins rounds of $2M–$20M at Seed, $12M–$34M at Series A and $25M–$130M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Daniel Gross participates in.
When did Daniel Gross last invest?
The most recent investment recorded for Daniel Gross closed in Jun 2026. Shizune tracks 101 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!